CONTACT Obsidian Therapeutics
Obsidian is pioneering cell and gene therapy, leading the next generation of engineered therapeutics. We are developing a novel pipeline of therapeutics, with our first TIL candidate due to advance into patients in 2022. We are applying our cytoDRiVE® platform technology through collaborations to enable discovery of novel therapies with the potential to expand our impact and reach a wider range of patients.
Corporate Headquarters
Obsidian Therapeutics
1030 Massachusetts Ave
Cambridge, MA 02138
Main Phone: (781) 806-6245
General Inquiries: info@obsidiantx.com
BD Inquiries: bd@obsidiantx.com